🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

FBIO FBIO

Company Profile ↓
$2.79
+48.40% 1Y
P/E-39.86
52W High$4.38
52W Low$1.82
EPS (TTM)$-0.07

Company Overview

FBIO (FBIO) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Recent Developments

  • Dec 2025 Revenue of $63.26M (+9.7% YoY); net profit $6.82M.
  • Trailing 12 Months Year-on-year growth — revenue +9.7%.
  • 5-Year Trend Long-term compounding — revenue CAGR 6.8%.

Growth & Price Performance

Compounded Sales Growth

5 Years:6.77%
1 Year:9.69%

Stock Price Performance

1 Year:+48.40%
6 Months:-9.71%
3 Months:+13.41%
1 Month:-6.69%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 38% of range
$1.82 $4.38
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • Golden Cross8d ago
  • RSI (14)37.96 · Neutral
Price Performance
1M-6.69%
3M+13.41%
6M-9.71%
1Y+48.40%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading 36.3% below its 52-week high.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-39.86
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
6.77%
Profit 5Y
-
Revenue (YoY)
9.69%
Earnings (YoY)
-

Profitability & Returns

ROCE
-51.71%
ROE
13.66%
ROA
3.67%
Profit Margin
10.77%
Op Margin
-
Gross Margin
-
EPS (Latest Qtr)
$2.82
EPS (TTM)
$-0.07

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$356.87M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
22.79%
Chg in Prom Hold
-
FII / Inst Holding
24.72%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$63.26M
EBITDA
-
Free Cash Flow
$-80.19M
Operating Cash Flow
$-65.78M
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue 0-500.00K025.00K--2.23M975.00K-2.78M4.40M2.52M7.54M5.90M6.82M5.17M8.99M6.48M9.25M9.77M12.92M9.46M9.47M11.59M17.84M21.09M23.93M18.89M16.53M12.43M17.39M34.75M13.03M14.90M14.63M13.14M16.41M17.63M16.04M
Gross Profit ---025.00K--1.91M934.00K-------------------------------
Operating Income -4.35M-4.96M-12.57M-7.76M-18.10M-12.96M-15.57M-17.04M-17.18M-32.22M-19.12M-25.50M-31.80M-30.62M-34.17M-25.40M-28.20M-41.21M-32.61M-25.29M-22.54M-21.53M-25.40M-23.04M-30.02M-42.86M-49.92M-47.27M-50.93M-50.73M-58.87M-50.10M-13.76M-36.57M-27.79M-22.09M-22.32M-36.47M-6.81M-7.74M
Net Income -4.59M-3.71M-12.06M-6.17M-18.16M-12.04M-12.21M-12.48M-12.98M-17.43M-11.98M-17.36M-27.12M-10.41M-21.02M-21.61M-16.64M-24.88M1.39M-13.10M-12.76M-12.37M-13.31M-15.55M-8.82M-3.54M-20.78M-15.76M-21.36M-22.51M-21.54M-24.78M-5.04M-15.42M-10.95M-12.87M-10.58M15.49M5.85M110.37M
Diluted EPS ---------------0.49---0.02---0.19---0.11-0.04-0.26-0.18-0.26-4.11-0.21-3.65-0.94-1.04-0.73-0.76-0.480.450.112.82
R&D Expense 1.61M-1.64M2.41M9.07M-7.74M6.35M7.32M-8.40M---24.96M---23.27M--15.12M17.27M13.76M20.15M33.83M28.08M36.72M33.13M29.90M39.51M32.14M20.35M24.84M12.67M9.45M----

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue ------00863.00K16.48M17.25M26.88M36.63M45.60M68.79M75.74M84.51M57.67M63.26M
Operating Income ---2.61M-9.24M-35.04M-27.18M-35.78M-20.65M-50.53M-65.71M-89.80M-120.00M-110.82M-94.27M-188.54M-203.56M-142.34M-110.38M-70.22M
Net Income -2.64M-3.80M-3.67M-9.98M-36.36M-27.61M-37.16M-20.39M-48.43M-55.09M-66.88M-84.15M-39.96M-46.53M-64.70M-86.58M-60.64M-46.00M6.82M
Diluted EPS ---------------0.79-15.97-8.47-2.69-0.07
R&D Expense --2.27M8.34M8.58M17.47M25.68M10.24M29.81M35.13M48.32M87.38M81.33M64.11M128.87M134.88M106.07M--

Balance Sheet (Annual)

Figures in USD.

Metric Jun 2006Dec 2006Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -----14.94M23.38M40.99M100.58M89.33M118.61M170.73M245.95M140.99M226.42M333.41M396.50M294.30M167.53M144.22M185.55M
Total Equity 0-123.00K-2.75M5.00K-15.90M-15.90M19.13M22.03M81.28M70.52M56.85M38.49M52.57M1.85M26.21M100.34M108.67M41.72M22.54M22.74M49.87M
Cash & Equivalents 0--7.00K1.51M14.86M23.16M40.20M99.52M49.76M98.18M88.29M94.95M65.51M136.86M233.35M305.74M178.27M80.93M57.26M79.38M
Long Term Debt ---------14.01M24.01M30.22M67.54M84.41M84.66M51.68M42.94M91.73M60.86M57.96M52.42M
Total Liabilities -----1.56M4.24M18.96M19.30M18.80M34.34M87.76M125.45M121.25M153.89M136.41M170.63M244.28M165.94M145.87M123.36M
Current Liabilities -----1.56M3.49M5.13M11.21M4.08M10.58M56.56M71.44M55.61M45.62M51.76M101.04M127.72M84.91M71.40M49.74M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -2.35M-5.68M-10.95M-23.19M-29.65M--20.38M-45.81M-81.31M-98.85M-94.96M-83.68M-116.54M-179.40M-128.22M-80.19M-65.78M
Investing Cash Flow -2.00K-13.00K-3.84M-279.00K-188.00K-7.88M-6.06M-40.22M18.82M20.10M-7.16M40.51M-22.93M-2.10M-15.00M10.12M
Financing Cash Flow 3.86M19.04M23.09M40.51M89.16M-60.92M42.91M150.38M50.65M146.71M172.41M148.99M75.32M32.74M70.64M77.44M
Capital Expenditure ---0-54.00K-40.00K-0-283.00K-6.37M-648.00K-7.08M-2.35M-1.93M-4.57M-2.71M-63.00K-0-
Free Cash Flow ---10.95M-23.25M-29.69M--20.66M-52.18M-81.95M-105.93M-97.31M-85.61M-121.11M-182.12M-128.29M-80.19M-
Share Buybacks ----------070.00K-----

Ratios (Annual)

Figures in %.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------------------
Operating Margin % ---------5,855.3%-398.7%-520.7%-446.4%-302.5%-206.7%-274.1%-268.8%-168.4%-191.4%-111.0%
Net Margin % ---------5,611.6%-334.3%-387.8%-313.0%-109.1%-102.0%-94.1%-114.3%-71.7%-79.8%10.8%
ROE % 96.2%-75,980.0%23.1%62.8%-190.0%-125.3%-45.7%-28.9%-85.2%-143.1%-127.2%-4,543.6%-152.4%-46.4%-59.5%-207.5%-269.0%-202.3%13.7%
ROCE % ----69.1%-176.3%-75.8%-40.0%-24.2%-46.8%-57.6%-51.5%-140.5%-61.3%-33.5%-63.8%-122.2%-172.3%-151.6%-51.7%

Shareholding Pattern

Insiders
22.79%
Institutions
24.72%
Public Float
32.01%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for FBIO

Google News hu, 30 Jul 2026

Fortress Biotech Just Netted $159 Million - Its Preferred Shares Could Be The Real Winner - Seeking Alpha

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQbTNoeG16RGdmSEhHaTFQeUM3Ull6ZUpfUzVlaGlWVHVfTDVkY0pxN0xMNW5jbmtNNmxadHVFcjNacTJRa2pFTEtlUTZCWks5T3M2Y2hobVdYUXZwRVBfOVM4Tm1PRUx6dFlRc3U3c0FVUmRaQnFiZU5ZWFZVb3FSMlFpZjVQQ1oyWUF6cT…

Google News hu, 25 Jun 2026

FBIO Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE5NS2tmWUV4YS11WlloZXRFVGlwTWpzVUkteGppbVNvcWpSMV8xTE5zSTdtc2RfV2ZmQk1ZWFRHcWh6MEZudTh4NnM3M1BYS044dkNiY3lWY2xsRXNselFGQndEVG5ZYTV5OXVWRUFEV0RWWnFNcGY1LURn?oc=5" target="_blank">FBI…

Google News Sun, 18 Jan 2026

Fortress Biotech, Inc. (NASDAQ:FBIO) Could Be Less Than A Year Away From Profitability - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxObXJNZEpJcGJ2RTViLWNNS2JfWWV5Q2xlRVh3OVdrWkQzQ190TEM1MzhhbllFMm9hWlBSZEo0R1BHS0xKRHBzZlg4ak5PV3d5a1ozNkZ2cjNQYzk5c21CYldaMjBuSXZwS0FudnNtQkQzTnhuUzRSN0tKM3U0cVRxcEZieDk?oc=5" targ…

Google News Wed, 24 Jun 2026

Fortress Biotech (NASDAQ: FBIO) CFO receives 400,000 RSU award - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNRTNJNUlfdGtXQVZSZ0FySGJFWUd1Tm9LeG9JRzBnd1VLWDBrNlpGaVc2VGtaWkd5UGdtLS1TLVRPU0J6TzhMbDQtN2dqblRGSTJhUlF3VmZrTERKVlpHQWx5YUZ3ck1Yd3B0T2xHQ3VNZmhrYlZUQTc4Snd4RHdLajU2dHRrUnBYVzFXbz…

Google News hu, 05 Feb 2026

Market Cool On Fortress Biotech, Inc.'s (NASDAQ:FBIO) Revenues Pushing Shares 28% Lower - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxPQ0VGejNIdGtmNk4wUHZMZGg1dFBfcmduQm5IZ2lCRGUwa0RoVDUxMHZzbDFlRERlb0YzS2s0REQwZ2pEQmlwVzZhLWg0OVhfY0xfbkFyUFJHdzFEZXVrZXMyTll6amsySDJGcTA2blJ2OHBtQ1ExWlFENUFFa2c0N0hWWWtYOXYySzhSaU…

Google News Sat, 25 Jul 2026

Fortress Biotech Inc (FBIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE95Slp0MVYyS0pNTFRpNVdMZ0UwRy1SMEhQWldiR215bmVUWVZBOEZDN3ZmS2dxLXJ6akVuR01rZF9MV1hZRjN5LUpNTWhEby1IVXV1TnpzVXRobnhReGlDdGtTaDFHampYNkZpdTZMV1U?oc=5" target="_blank">Fortress Biotech…

FBIO — Frequently Asked Questions

What is the current share price of FBIO?

As of 2026-08-05 17:25 PDT, FBIO trades at $2.79 on NASDAQ/NYSE. Its 52-week range is $1.82 to $4.38.

What is the P/E ratio of FBIO?

FBIO trades at a trailing price-to-earnings (P/E) ratio of -39.86.

What is the return on equity (ROE) of FBIO?

FBIO has a return on equity (ROE) of 13.66%. Its return on capital employed (ROCE) is -51.71%.

Is FBIO a good stock to buy?

This page provides a data-driven analysis of FBIO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space